在SARS-CoV-2管理中的变革性方法:疫苗,治疗方法和未来的方向
Ankita Saha1, Shweta Choudhary1, Priyanshu Walia1
1Department of Biosciences and Bioengineering, Indian Institute of Technology Roorkee, Uttarakhand, 247667, India.
Virology
|January 31, 2025
概括
随着COVID-19的流行,人们越来越需要先进的疫苗和抗病毒药物. 整合这些策略对于应对未来的病毒威胁和耐药性的准备至关重要.
科学领域:
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 随着COVID-19的流行,人们迫切需要快速的治疗和预防干预措施.
- 抗病毒药物对于感染者,免疫力低下者或未接种疫苗的个人来说是非常重要的辅助对策.
- 长期COVID,动物传染性溢出,病毒进化和耐药性造成了持续的健康问题.
研究的目的:
- 提供SARS-CoV-2疫苗开发策略的全面概述,包括经典和下一代方法.
- 审查最近在抗SARS-CoV-2药物发现方面的突破,重点关注病毒和宿主目标.
- 为了解决安全风险,临床试验数据和耐药变种的出现.
主要方法:
- 对SARS-CoV-2的经典和下一代疫苗开发策略的审查.
- 从疫苗和抗病毒试验中分析临床和实验数据.
- 对抗SARS-CoV-2药物发现的检查,包括目标识别和机械代表性分子.
主要成果:
- 疫苗一直是最前线的防御,新的策略正在不断发展.
- 针对病毒或宿主因素的抗病毒疗法显示出有前途,有几种在临床研究中.
- 病毒进化和耐药性需要在疫苗和抗病毒药物中不断创新.
结论:
- 整合疫苗和抗病毒疗法对于打击COVID-19和未来的病毒爆发至关重要.
- 需要创新策略来解决病毒演变和新兴耐药性的问题.
- 应对未来的流行病的准备依赖于结合疫苗接种和抗病毒治疗的多方面方法.
相关概念视频
Cancer Vaccines
329
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
329
Tumor Immunotherapy
464
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
464
Vaccinations
43.9K
Overview
43.9K
Viral Mutations
32.1K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.1K


